Summary
The BE EBCP Mirror Group (MG) is a national cancer stakeholder
platform that supports the implementations of European cancer
initiatives in Belgium by fostering collaboration among stakeholders to
address cancer care and control needs. Despite its successes in engaging
over 400 experts and facilitating EU-funded projects, challenges such
as limited resources and aligning stakeholder positions remain.
Read more
To tackle the rising burden of cancer, the European Commission has launched two major initiatives: Europe’s Beating Cancer Plan (EBCP) and the Mission on Cancer (MoC).
These initiatives are designed to address every stage of the disease
starting with the prevention and diagnosis of cancer, the improvement of
patient treatment and care, and the enhancement of the quality of life
for cancer patients and survivors. To complement these European efforts,
Belgium has taken proactive steps to ensure that national efforts align
with the EBCP and MoC.
A national coordination mechanism
has been put in place to address gaps and needs in cancer care and to
ensure that both EU funds and national resources are optimally used to
improve outcomes for cancer patients in Belgium.
Federal Health
Minister Frank Vandenbroucke appointed the Cancer Centre of Sciensano to
coordinate the implementation of the EBCP in Belgium. The “Be EBCP Mirror Group”
(MG), launched in October 2021, is a large-scale national cancer
stakeholder platform created to mirror the key areas of the EBCP and
MoC. It includes over 400 representatives from federal and regional
health agencies, universities, patient organizations, and professional
societies, among others.
These TWGs are led by experts from the
Cancer Centre of Sciensano, and regular meetings are held throughout the
year to engage stakeholders in discussions about cancer care
improvements.
The MG adopts a participatory approach, meaning that it involves experts and stakeholders at all levels of cancer care to ensure that policy recommendations are translated into effective, practical interventions.
Since its launch, the BE EBCP Mirror Group has facilitated discussions on over 80 EU cancer projects from 2021 to 2024, aligning Belgium’s national priorities with European initiatives contributing to projects in key
areas such as prevention, early detection, diagnosis, treatment,
quality of life, and patient engagement, fostering collaboration and
advancing cancer care policies.
Enablers: The BE EBCP Mirror Group benefits from government support, with a cabinet mandate and funding provided by RIZIV-INAMI, the National Health and Disability Insurance Agency (Funding).
A comprehensive stakeholder mapping conducted at the launch of the MG
ensured effective outreach, involving over 400 experts across various
sectors of the Belgian cancer field. The MG facilitates Belgium’s
participation in the EBCP and MoC via a dynamic process led by
Sciensano’s in-house experts, who also moderate discussions within the
Thematic Working Groups (TWGs) to ensure quality assurance (Governance).
The MG also partners with National Contact Points (NCPs) and National
Focal Points (NFPs) to increase Belgian participation in cancer-related
EU calls. To increase transparency and streamline BE partner activities,
a data sharing agreement with the Federal Public Planning Service
Science Policy (BELSPO) was signed, resulting in more precise monitoring
of Belgian participation in EU research projects related to cancer. A
multimedia communication strategy tailored to different stakeholder
groups (via newsletters, websites, podcasts and policy briefs) enhances
engagement (Resources). Additionally, feedback loops enable the
anticipation of potential implementation issues, and participation in
European initiatives, such as the ECHoS project, facilitates
cross-border knowledge exchange and strengthens Belgium’s position
within the broader European cancer landscape (Service Delivery).
Barriers:
Limited resources restrict the group’s ability to participate in all
available EU funding opportunities related to cancer, leading to missed
opportunities for collaboration and funding (Resources).
Additionally, the MG faces difficulties in closely monitoring projects
where the Cancer Centre of Sciensano is not directly involved, which
limits oversight and coordination (Governance). The reliance on
pro bono participation from experts and stakeholders in the Thematic
Working Groups (TWGs) further exacerbates challenges, as there is no
budget to support the participation of smaller organizations or patient
groups (Financing). A national cancer plan could facilitate the
coordination of efforts and a structured implementation of
cancer-related initiatives. Conflicts of interest, particularly when
partners apply for competitive EU grants, may obstruct MG’s monitoring
and reporting activities. Furthermore, managing expectations about the
MG’s role proves challenging (Service delivery), as it is not a legal entity and cannot directly apply for EU projects.
Lessons learned: The Be EBCP Mirror Group (MG) highlights the value of a participatory approach in cancer care, optimizing resources, fostering coordination, and prioritizing patient-centredness.
By engaging experts and strengthening collaboration, the MG improves
access to European Commission funding and enhances health system efficiency. Government support and structural sustainability ensure its long-term impact. The
MG adapts its structure based on stakeholder feedback, enabling
responsive adjustments and activities like benchmarking and strategic
foresight. However, aligning the priorities of diverse
stakeholders remains challenging, but the MG’s focus on coordination and
continuous feedback drives progress in cancer care and policy
implementation.